High Court Sends Myriad Gene Patent Row Back To Fed. Circ.
The U.S. Supreme Court on Monday ordered the Federal Circuit to take another look at its finding that breast cancer genes isolated by Myriad Genetics Inc. are patentable, in light of...To view the full article, register now.
Already a subscriber? Click here to view full article